Pharmaceuticals

CLEARSIDE BIOMEDICAL INC

Clearside Biomedical Inc. released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 3.023 M and actual EPS of USD -3.6106

Clearside Biomedical Inc. released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 201 K (forecast USD 88 K), actual EPS USD -1.141

Clearside Biomedical Inc. released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 1.038 M (forecast USD 122.86 K), actual EPS USD -1.5428

Clearside Biomedical Inc. released FY2024 9 Months Earnings on November 14, 2025 (EST), Actual Revenue: USD 1.358M, Actual EPS: USD -5.593

Clearside Biomedical Inc. released FY2024 Semi-Annual earnings on August 8, 2025 (EST), actual revenue USD 320K, actual EPS USD -4.0164

CLEARSIDE BIOMEDICAL INC released FY2024 Q2 earnings on August 8 (EST), actual revenue USD 90K (forecast USD 126.5K), actual EPS USD -1.5242

Clearside Biomedical Inc. released FY2025 Q2 earnings on August 8 (EST), actual revenue USD 492K (forecast USD 169.86K), actual EPS USD -0.8661

Clearside Biomedical Inc. released FY2025 Semi-Annual earnings on August 8 (EST), actual revenue USD 2.822M, actual EPS USD -2.4651

Clearside Biomedical Inc. released FY2025 Q1 earnings on May 15, 2025 (EST), actual revenue USD 2.33 M (forecast USD 197.83 K), actual EPS USD -1.6035

Clearside Biomedical Inc. released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 230 K (forecast USD 681.25 K), actual EPS USD -2.5259

Clearside Biomedical Inc. released FY2024 Q4 earnings on March 27, 2025 (EST), actual revenue USD 306K (forecast USD 294.43K), actual EPS USD -1.4448

Clearside Biomedical Inc. released FY2022 earnings on March 27, 2025 (EST), actual revenue USD 1.327 M (forecast USD 1.094 M), actual EPS USD -8.2087

Clearside Biomedical Inc. released FY2023 earnings on March 27, 2025 (EST), actual revenue USD 8.226 M (forecast USD 6.129 M), actual EPS USD -7.8838

Earnings report released on March 27, 2025 (BJT): Actual revenue USD 6.345 M, Actual EPS USD -1.1614

Clearside Biomedical Inc. released FY2024 annual earnings on March 27 (EST), actual revenue USD 1.664 M (forecast USD 1.676 M), actual EPS USD -6.9817

Clearside Biomedical Inc. released FY2023 Q3 earnings on November 12 (EST), actual revenue USD 859 K (forecast USD 132.2 K), actual EPS USD -2.2425

CLSDQ

Treasure Gbl

SMX Security Matters

Wheeler Real Estate

Gulf Resources

DigitalBridge

Toro

Dreamland

Lichen

Springview

Alumis

Eli Lilly

ROCHE HOLDINGS AG

Roche

Astrazeneca

NOVARTIS AG

Novo Nordisk AS

Chugai Pharmaceutical

UCB S.A.

Daiichi Sankyo

Otsuka Pharmaceutical

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap